Literature DB >> 6207196

Human serum spreading factor: relationship to somatomedin B.

D W Barnes, T P Foley, M C Shaffer, J E Silnutzer.   

Abstract

Human serum spreading factor (SF) is a blood glycoprotein that promotes the attachment and spreading of a variety of cell types in serum-free culture, as well as affecting migration, proliferation and differentiation of some cell types under appropriate conditions. The amino acids occupying 17 of the first 23 positions from the NH2-terminus of SF were determined, and this sequence was found to be identical to that reported for somatomedin B (SmB) by Fryklund and Sievertsson (FEBS Letters 87:55). Immunoassay of SF in plasma from subjects with conditions related to altered GH levels indicated that serum SF levels were not GH-responsive to any marked degree. No effect of purified SF was observed in a cell growth assay used previously to detect mitogenic activity in SmB preparations. These results support the conclusion that SF acts as a substratum molecule to elicit its biological effects in cell culture, and does not act in a manner similar to peptide growth factors. These data also are consistent with the conclusion of Heldin et al. (Science 213:1122) that the mitogenic activity of SmB preparations is derived from a contaminating factor, and is not due to SmB.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207196     DOI: 10.1210/jcem-59-5-1019

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Effects of fibronectin-related peptides on cell spreading.

Authors:  J E Silnutzer; D W Barnes
Journal:  In Vitro Cell Dev Biol       Date:  1985-01

2.  Human and mouse S-protein mRNA detected in northern blot experiments and evidence for the gene encoding S-protein in mammals by Southern blot analysis.

Authors:  M Solem; A Helmrich; P Collodi; D Barnes
Journal:  Mol Cell Biochem       Date:  1991-02-02       Impact factor: 3.396

3.  Binding of Staphylococcus aureus by human serum spreading factor in an in vitro assay.

Authors:  J I Fuquay; D T Loo; D W Barnes
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  SCF + G-CSF treatment in the chronic phase of severe TBI enhances axonal sprouting in the spinal cord and synaptic pruning in the hippocampus.

Authors:  Xuecheng Qiu; Suning Ping; Michele Kyle; Lawrence Chin; Li-Ru Zhao
Journal:  Acta Neuropathol Commun       Date:  2021-04-08       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.